ContraFect Corp Stock Price, News & Analysis (NASDAQ:CFRXU)

$6.11 -0.16 (-2.55 %)
(As of 11/17/2017 12:28 PM ET)
Previous Close$6.11
Today's Range$5.75 - $6.60
52-Week Range$5.24 - $7.87
VolumeN/A
Average VolumeN/A
Market Capitalization$117.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About ContraFect Corp (NASDAQ:CFRXU)

ContraFect Corp logoContraFect Corporation (ContraFect ) is a biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. It intends to address drug-resistant infections using its therapeutic product candidates from its lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses (regions that are not prone to mutation). Its product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia, and CF-404, a combination of mAbs for the treatment of life-threatening seasonal and pandemic varieties of influenza. CF-301 and CF-302 are bacteriophage lysins with potent activity against Staph aureus infections.


Industry, Sector and Symbol:
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Sector: Biotechnology & Medical Research - NEC
  • Symbol: NASDAQ:CFRXU
  • CUSIP: N/A
  • Web: www.contrafect.com
Misc:
  • Outstanding Shares: 24,740,000
 

Frequently Asked Questions for ContraFect Corp (NASDAQ:CFRXU)

What is ContraFect Corp's stock symbol?

ContraFect Corp trades on the NASDAQ under the ticker symbol "CFRXU."

Who are some of ContraFect Corp's key competitors?

Who are ContraFect Corp's key executives?

ContraFect Corp's management team includes the folowing people:

  • Steven C. Gilman Ph.D., Chairman of the Board, Chief Executive Officer (Age 64)
  • Joshua B. Muntner, Co-Chief Executive Officer, Senior Vice President - Business Development (Age 48)
  • Michael Messinger CPA, Co-Chief Executive Officer, Vice President - Finance (Age 42)
  • Roger Pomerantz M.D., Vice Chairman of the Board (Age 60)
  • Lisa R. Ricciardi, Chief Operating Officer, Director (Age 56)
  • Nancy Dong, Vice President, Controller
  • Cara M. Cassino M.D., General Counsel, Secretary, Chief Medical Officer (Age 55)
  • Natalie Bogdanos, General Counsel and Corporate secratary (Age 46)
  • Sol J. Barer Ph.D., Lead Independent Director (Age 69)
  • Isaac Blech, Independent Director (Age 67)

How do I buy ContraFect Corp stock?

Shares of ContraFect Corp can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ContraFect Corp's stock price today?

One share of ContraFect Corp stock can currently be purchased for approximately $6.11.

How big of a company is ContraFect Corp?

ContraFect Corp has a market capitalization of $117.86 million.

How can I contact ContraFect Corp?

ContraFect Corp's mailing address is 28 Wells Ave Ste 3, YONKERS, NY 10701-7045, United States. The biotechnology company can be reached via phone at +1-914-2072300.


MarketBeat Community Rating for ContraFect Corp (NASDAQ CFRXU)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about ContraFect Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for ContraFect Corp (NASDAQ:CFRXU)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for ContraFect Corp (NASDAQ:CFRXU)

Price Target History for ContraFect Corp (NASDAQ:CFRXU)

Analysts' Ratings History for ContraFect Corp (NASDAQ:CFRXU)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for ContraFect Corp (NASDAQ:CFRXU)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ContraFect Corp (NASDAQ:CFRXU)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ContraFect Corp (NASDAQ:CFRXU)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ContraFect Corp (NASDAQ CFRXU)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for ContraFect Corp (NASDAQ:CFRXU)

Latest Headlines for ContraFect Corp (NASDAQ CFRXU)

Source:

Social Media

Financials

Financials are not available for this stock.

Chart

ContraFect Corp (NASDAQ CFRXU) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.